Tailoring DAPT in the setting of ACS patients

Sponsored by OrbusNeich

Chairpersons: H. Gamra, M. Haude
Panellist: A. Al Nooryani

Learning Objectives

  • To review the visibility of 3-months vs. 12-months DAPT in ACS patients
  • To learn more about the rationale behind stent selection in patients with high risks of bleeding
  • To share your own clinical experience in similar scenarios and learn from each other